Sort   by:  
 Page size 
UnknownIL-24 improves efficacy of CAR-T cell therapy by targeting stemness of tumor cells.
Not available
S-EPMC11015030 | biostudies-literature
UnknownSulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway.
Not available
S-EPMC8614004 | biostudies-literature
UnknownA novel antiviral lncRNA, EDAL, shields a T309 O-GlcNAcylation site to promote EZH2 lysosomal degradation.
Not available
S-EPMC7465408 | biostudies-literature
UnknownCancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC.
Not available
S-EPMC6371476 | biostudies-literature
UnknownTumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR-RUNX1.
Not available
S-EPMC10681900 | biostudies-literature
UnknownXELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.
Not available
S-EPMC10987514 | biostudies-literature
Sort   by:  
 Page size